"I'm In" - Duncan Bannatyne Judges "Switch Ash for Cash" Schools Competition
LONDON, March 11 /PRNewswire/ --
- With Photo
To mark this year's No Smoking Day, three 'mini' entrepreneurs today went
head-to-head to win a GBP2,000 investment from TV Dragon Duncan Bannatyne. In
a re-enactment of the TV challenge, the school children faced their toughest
REGiMMUNE to present GvHD data at the 50th ASH Annual Meeting
Mountain View, CA December 5, 2008 REGiMMUNE Corporation, a privately held biopharmaceutical company focused on developing technologies and products for immune disorders, will present preclinical data on the company's potential therapeutic treatment for Graft versus Host Disease (GvHD) at the Am...
Zevalin Data to be Presented at ASH 2008
SEATTLE, Dec. 4 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc. (CTI)
(Nasdaq and MTA: CTIC) today announced presentations or posters of interest
related to Zevalin(R) (ibritumomab tiuxetan) to be presented at the 50th
Annual Meeting of the American Society of Hematology (ASH), December 5-9, 200...
Horse Drawn Hearse and Ash Scattering by Balloon - Hello LAFuneralGuide.com!
First-ever Online Funeral Planning Guide for Los Angeles
SEATTLE, Nov. 11 /PRNewswire/ -- Brides planning a wedding have over
eight online wedding guides to help them explore ideas and connect with
local Los Angeles vendors. On the other hand, families planning a funeral
have none -- u...
Researchers to Present Additional Data on Soliris(R) (eculizumab) for the Treatment of PNH at the ASH Annual Meeting
Initial Physician Experience with Eculizumab in Patients with Other
Rare Complement-Mediated Diseases also to be Presented
CHESHIRE, Conn., Nov. 10 /PRNewswire-FirstCall/ -- Alexion
Pharmaceuticals, Inc. (Nasdaq: ALXN ) today announced that the American
Society of Hematology (ASH) has publi...
CuraGen and TopoTarget Report Belinostat Results Presented at ASH and Provide Regulatory Update Following End-of-Phase II Meeting with FDA
- Conference call to be hosted on Tuesday, December 11th at 9:00 a.m. Eastern time -
- Encouraging clinical results presented at ASH
from the ongoing Phase II trial in T-cell lymphomas -
- Positive End-of-Phase II meeting held with the FDA for b...
Proteolix Announces Clinical Results With Carfilzomib to be Reported at ASH 2007 Annual Meeting
SOUTH SAN FRANCISCO, Calif., Dec. 6 /PRNewswire/ -- Proteolix, Inc.
announced today that data from two Phase 1 clinical studies using
intravenous carfilzomib (PR-171) are to be presented at the 2007 American
Society of Hematology (ASH) Annual Meeting in Atlanta, Georgia, December
8-10, 2007. C...
Kiadis Pharma Presents ATIR and Rhitol Data at ASH and NIH Presentation on ATIR at ASH
AMSTERDAM, November 23 /PRNewswire/ -- Kiadis Pharma announces today
that there will be three presentations on its products ATIR and Rhitol in
poster sessions at the 2007 Annual Meeting of the American Society of
Hematology (ASH) December 8-11 in Atlanta, Georgia, USA. Data will be
Chilean volcano captured blasting ash
Chiles Chaiten Volcano is shown spewing ash
and smoke (centre left of image) into the air for hundreds of km over Argentinas Patagonia Plateau in this Envisat image acquired on 5 May 2008.
The 1000 m-high volcano had been dormant for thousands of years before erupting on 2 May, causing the evac...
HVO Launches Hematology Program in Uganda in Partnership with ASH
WASHINGTON, March 28 /PRNewswire-USNewswire/ -- Health Volunteers
Overseas (HVO) and the American Society of Hematology (ASH) are pleased to
announce the establishment of the first HVO hematology training program, at
Mulago Hospital located in Kampala, Uganda. Mulago Hospital is a 1500-bed
ash in Medical Technology
First Clinical Experience With Soliris(R) in Treating Patients With Two Rare Complement-Mediated Diseases Presented at ASH Annual Meeting
CHESHIRE, Conn., Dec. 7 /PRNewswire-FirstCall/-- Soliris(R) (eculizumab),
a terminal complement inhibitor developed by Alexion Pharmaceuticals, Inc.
(Nasdaq: ALXN ) for the treatment of paroxysmal nocturnal hemoglobinuria (PNH),
was associated with an improvement in hematologic parameters in a l...
More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies
- Tasigna front-line data demonstrating potential in newly diagnosed patients with a life-threatening type of leukemia to be featured in two oral sessions at ASH
- Exjade results at ASH
to show benefits for chronically transfused patients by significantly reducing toxic iron that can dama...
TargeGen Affiliates Scheduled for Oral Presentation of Interim Clinical Trial Data at 2008 ASH Meeting in San Francisco for TG101348, a Potent, Selective, Oral JAK2 Inhibitor in Myeloproliferative Disease Patients
SAN DIEGO, Dec. 1 /PRNewswire/ -- TargeGen has announced that an oral
presentation of preliminary results from a multi-center, US-based clinical
trial of TG101348 in myeloproliferative disease patients has been scheduled at
the 2008 American Society of Hematology (ASH) Meeting.
Data Presented at 2007 ASH Meeting Demonstrate Activity of Forodesine HCl as a Single Agent or in Combination With Bendamustine in Certain Types of Leukemia and Lymphoma
BIRMINGHAM, Ala., Dec. 14 /PRNewswire-FirstCall/ -- BioCryst
Pharmaceuticals, Inc. (Nasdaq: BCRX ) today reported clinical trial and in
vitro data evaluating forodesine HCl, the Company's lead anti-cancer
compound, in the treatment of certain types of leukemias and lymphomas.
ASCO and ASH Release Updated Guideline on the Use of Chemotherapy-Related Anemia Treatments in Cancer Patients
WASHINGTON, Oct. 22 /PRNewswire-USNewswire/ -- Today, the American
Society of Hematology (ASH) and the American Society of Clinical Oncology
(ASCO) have released an updated joint guideline on the use of
erythropoiesis-stimulating agents (ESAs), a class of drugs that stimulate
the bone marrow t...
Sunesis Announces New Data on Voreloxin for Acute Myeloid Leukemia To Be Presented at ASH
-- Conference Call Scheduled for Tuesday, December 9 at 11:00 am ET to Discuss Phase 2 Study Results in AML --
SOUTH SAN FRANCISCO, Calif., Dec. 1 /PRNewswire-FirstCall/ -- Sunesis Pharmaceuticals, Inc. (Nasdaq: SNSS ), a biopharmaceutical company focused on the development and comme...
Kosan Presents Updated Data on Hsp90 Inhibitor, Tanespimycin, in Multiple Myeloma at Ash
HAYWARD, Calif., Dec. 8 /PRNewswire-FirstCall/ -- Kosan Biosciences
Incorporated (Nasdaq: KOSN ) presented updated data from a dose-escalating
Phase 1b clinical trial of Hsp90 inhibitor tanespimycin (KOS-953) in
combination with bortezomib (Velcade(R)), showing durable antitumor
activity and ...
TargeGen Announces Planned Initiation of Clinical Trial of JAK2 Inhibitor TG101348 in Myeloproliferative Disease Patients, and Presentations at ASH
SAN DIEGO, Dec. 6 /PRNewswire/ -- TargeGen, Inc. today announced that
the Company's recently submitted IND for TG101348 is now active and the
Company plans to initiate a multi-center clinical trial of TG101348, an
internally discovered, oral, potent, and highly selective JAK2 inhibitor in
Data Presented at ASH Demonstrate Nebivolol Lowers Blood Pressure
as Long-Term Monotherapy and in Combination Therapy
Data Also Show Nebivolol Lowers Blood Pressure in Obese and
Non-Obese Hypertensive Patients
CHICAGO, May 21, 2007 /PRNewswire-FirstCall/ -- Forest
Laboratories, Inc. today presented positive data from two clinical
studies and one pooled analysis of nebivolol, a selective beta
1-blocker with vasodi...
University of Michigan Study Shows SEQUENOM's MassARRAY Technology Identifies HPV Infections Missed by Standard Hybridization Test
...e, Anthony W. Opipari, Mack T. Ruffin, IV, Linda M. Kalikin, and David M. Kurnit.
This work was supported in part by grants from the Mary Kay ash
Charitable Foundation (DMK), SensiGen, LLC (DMK), and the National Cancer Institute of the National Institutes of Health [K24 CA080846 (MTR), K07 CA12...
ash in Biological News
Emerald Spectre haunts Ontario's ash forests
A new study shows that while we're winning isolated battles, we could well lose the war to prevent the devastating spread of the emerald ash
borer in eastern Canada and the United States. It's a failure that would cost billions of dollars in lost timber and ornamental trees, and dramatically change...
August 2009 Geology and GSA Today media highlights
...frica. By analyzing and dating 205 zircon grains extracted from deep-marine ash
beds of the western Karoo (using an high-resolution microprobe [SHRIMP-RG] ...the recovery of late Pleistocene mammal fossils. By using numerous volcanic ash
beds that characterize the fossil-rich strata to determine the age and corr...
Global sunscreen won't save corals
...he upper atmosphere. This would partially block incoming sunlight before it reached the Earth's surface, lowering global temperatures just as volcanic ash
from the Mount Pinatubo did following its eruption in 1991. But critics have warned that such a scheme might also alter rainfall patterns, damage the ...
CU-Boulder study shows Maya intensively cultivated manioc 1,400 years ago
...uried and exquisitely preserved under a blanket of ash
by a volcanic eruption in present-day El Salvador ...jacent to Ceren, which was buried under 17 feet of ash
and is considered the best preserved ancient farmi...oc," said Sheets, who discovered Ceren in 1978.
hollows in the manioc planting beds at Ceren left ...
Fossil bone bed helps reconstruct life along California's ancient coastline
...uvenile specimens, the team also discounted the hypothesis that this was a breeding ground for early seals such as Allodesmus. The absence of volcanic ash
makes a volcanic catastrophe unlikely, while the presence of land mammal fossils makes red tide an unlikely cause.
"These animals were dying over t...
Study compares sound from exploding volcanoes with jet engines
Large-amplitude infrasonic signals from volcanic eruptions are currently used in a prototype real-time warning system that informs the Volcanic ash
Advisory Center (VAAC) when large infrasonic signals have come from erupting volcanoes. Researchers hope this new information can improve hazard mitig...
April 2009 Geology and GSA Today media highlights
...anism can have significant environmental impact because of the discharge of ash
and volatiles directly into the atmosphere and oceans. Jicha et al. compile...basalts had lesser effects on the biosphere. The cooling effect of volcanic ash
and sulphate aerosols injected into the stratosphere during Plinian eruptio...
European satellites provide new insight into ozone-depleting species
...easured by a space instrument.
In August 2008, the Kasatochi Volcano in Alaska's Aleutian Islands erupted explosively, sending a cloud of volcanic ash
and gas more than 11 km into the atmosphere.
The following day, scientists from the Brussels-based Belgian Institute for Space Aeronomy identified...
January-February GSA Bulletin media highlights
...ither intrusively through inflation or extrusively through lava flow and/or ash
fall emplacement. Higher heat flow during Noachian time, or geothermal heat... similar to the modern boreal forest of central Alaska. Associated volcanic ash
beds suggest that this buried forest bed is about two million years old, so...
Urban trees enhance water infiltration
...ds and simultaneously provide rooting space for trees. In this study, green ash
trees increased the average infiltration rate by 27 fold compared with unpl...6 g cm‑3) by a woven geotextile in 102-liter containers. The roots of ash
trees planted in the structural soil penetrated both the geotextile and the...
ash in Biological Technology
Data Presented at ASH Annual Meeting Indicates the Potential of T-Cell Engaging BiTE Antibody Blinatumomab as a Consolidation Treatment for Aggressive Leukemias
Interim Data from a Phase 2 Clinical Trial in B-Precursor Acute Lymphoblastic Leukemia Show that Blinatumomab is Able to Eliminate Minimal Residual Disease
BETHESDA, Md., Dec. 8 /PRNewswire-FirstCall/ -- Micromet, Inc. (Nasdaq: MITI ), a biopharmaceutical company developing novel, propr...
Vion Pharmaceuticals to Present Survival Data on Laromustine at ASH Annual Meeting
Company Introduces New Trade Name Onrigin(TM) for Laromustine
NEW HAVEN, Conn., Dec. 4 /PRNewswire-FirstCall/ -- VION PHARMACEUTICALS, INC. (OTC Bulletin Board: VION) today made several announcements related to events in connection with the 50th American Society of Hematology Annua...
Aegera Therapeutics' phase 1/2 clinical trial results selected for oral presentation at 2008 ASH Annual Meeting
MONTREAL, Nov. 25 /PRNewswire/ - Aegera Therapeutics Inc. today announced that data from its phase 1/2 clinical trial of the XIAP antisense oligonucleotide, AEG35156, will be highlighted in an oral presentation at the 50th Annual Meeting of the American Society of Hematology (ASH) in San Francisco...
Rigel to Host Conference Call to Discuss Phase 2 Study Results of R788 in Lymphoma Presented at ASH
SOUTH SAN FRANCISCO, Calif., Dec. 3 /PRNewswire-FirstCall/ -- Rigel
Pharmaceuticals, Inc. (Nasdaq: RIGL ) today announced that members of Rigel's
senior management team will host a conference call with simultaneous webcast
on Sunday, December 7, 2008, at 4:00 p.m. PST, to discuss the results of
Genmab A/S: Ofatumumab Pivotal CLL Data to be Presented at ASH
Responses Significantly Correlated to Overall Survival
Summary: Three ofatumumab Abstracts Have Been Accepted for Presentation at the ASH
Meeting December 6-9, 2008
COPENHAGEN, November 10 /PRNewswire-FirstCall/ -- Genmab A/S (OMX: GEN)
announced today that three of...
AEterna Zentaris Discloses Preliminary Phase 2 Trial Results for Perifosine in Combination with Radiotherapy for Non-Small Cell Lung Cancer
...ine is dosed 50mg or 100mg daily until progression. Recently, positive Phase 2 data for multiple myeloma and metastatic colon cancer were presented at ash
and ASCO meeting, respectively."
Perifosine is a novel, first-in-class, oral anti-cancer agent that modulates several key s...
Amniotic Fluid May Provide New Source of Stem Cells for Future Therapies
...he immunologic, hemostatic, and vascular systems, by promoting research, clinical care, education, training, and advocacy in hematology. In September, ash
launched Blood: The Vital Connection ( www.bloodthevitalconnection.org ), a credible online resource addressing bleeding and clotting disorders,...
Just Say No To Charcoal! New Eco-Friendly Alternative Grills Faster, Burns Cleaner And Greener
...east. While the FlameDisk heat output is similar to charcoal, it creates no ash
or soot, meaning there's no messy cleanup. After the solid ethanol fuel bur...inutes --much faster than charcoal, which can take hours to cool before the ash
can be safely disposed. This ability to cool off rapidly gives FlameDisk gr...
BioCryst Reports Fourth Quarter and Year End 2008 Financial Results and Provides Corporate Update
...evere chronic plaque psoriasis. Results showed BCX-4208 was safe and well tolerated.
BioCryst also presented a poster at ash
entitled, "BCX-4208 (RO5092888), a Purine Nucleoside Phosphorylase (PNP) Inhibitor is a Novel, Potent Orally Active Anti T- and B-Cell Agent." Findin...
Sunesis Pharmaceuticals Provides Year-End Clinical Update on Voreloxin
...t that Schedule B is better tolerated by patients, while maintaining anti-leukemic activity. New data on the 21 patients on Schedule B reported on at ash
indicate 6 have achieved a CR or CRp, while 2 are awaiting hematologic count recovery. In addition to improved tolerability, the 30-day all-cause mor...
ash in Biological Dictionary
...l rooms, vacations, and rental cars with Kayak.com. Search hundreds of travel sites, compare results, and buy direct. Watch Clones music video by ash
now at Yahoo! Music. Access free music videos, song lyrics, online radio and music downloads. ...